rs2227543
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001354840.3(CXCL8):c.*157C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.371 in 590,280 control chromosomes in the GnomAD database, including 43,050 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.32 ( 8953 hom., cov: 31)
Exomes 𝑓: 0.39 ( 34097 hom. )
Consequence
CXCL8
NM_001354840.3 3_prime_UTR
NM_001354840.3 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.448
Genes affected
CXCL8 (HGNC:6025): (C-X-C motif chemokine ligand 8) The protein encoded by this gene is a member of the CXC chemokine family and is a major mediator of the inflammatory response. The encoded protein is commonly referred to as interleukin-8 (IL-8). IL-8 is secreted by mononuclear macrophages, neutrophils, eosinophils, T lymphocytes, epithelial cells, and fibroblasts. It functions as a chemotactic factor by guiding the neutrophils to the site of infection. Bacterial and viral products rapidly induce IL-8 expression. IL-8 also participates with other cytokines in the proinflammatory signaling cascade and plays a role in systemic inflammatory response syndrome (SIRS). This gene is believed to play a role in the pathogenesis of the lower respiratory tract infection bronchiolitis, a common respiratory tract disease caused by the respiratory syncytial virus (RSV). The overproduction of this proinflammatory protein is thought to cause the lung inflammation associated with csytic fibrosis. This proinflammatory protein is also suspected of playing a role in coronary artery disease and endothelial dysfunction. This protein is also secreted by tumor cells and promotes tumor migration, invasion, angiogenesis and metastasis. This chemokine is also a potent angiogenic factor. The binding of IL-8 to one of its receptors (IL-8RB/CXCR2) increases the permeability of blood vessels and increasing levels of IL-8 are positively correlated with increased severity of multiple disease outcomes (eg, sepsis). This gene and other members of the CXC chemokine gene family form a gene cluster in a region of chromosome 4q. [provided by RefSeq, May 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.418 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CXCL8 | NM_000584.4 | c.284+161C>T | intron_variant | Intron 3 of 3 | ENST00000307407.8 | NP_000575.1 | ||
CXCL8 | NM_001354840.3 | c.*157C>T | 3_prime_UTR_variant | Exon 3 of 3 | NP_001341769.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.321 AC: 48639AN: 151618Hom.: 8956 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
48639
AN:
151618
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.389 AC: 170568AN: 438542Hom.: 34097 Cov.: 5 AF XY: 0.387 AC XY: 90070AN XY: 232562 show subpopulations
GnomAD4 exome
AF:
AC:
170568
AN:
438542
Hom.:
Cov.:
5
AF XY:
AC XY:
90070
AN XY:
232562
Gnomad4 AFR exome
AF:
AC:
1490
AN:
11234
Gnomad4 AMR exome
AF:
AC:
4325
AN:
14710
Gnomad4 ASJ exome
AF:
AC:
4653
AN:
13040
Gnomad4 EAS exome
AF:
AC:
9567
AN:
29452
Gnomad4 SAS exome
AF:
AC:
12537
AN:
36618
Gnomad4 FIN exome
AF:
AC:
15643
AN:
41314
Gnomad4 NFE exome
AF:
AC:
112217
AN:
265376
Gnomad4 Remaining exome
AF:
AC:
9436
AN:
24876
Heterozygous variant carriers
0
4950
9901
14851
19802
24752
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
568
1136
1704
2272
2840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.321 AC: 48641AN: 151738Hom.: 8953 Cov.: 31 AF XY: 0.317 AC XY: 23463AN XY: 74098 show subpopulations
GnomAD4 genome
AF:
AC:
48641
AN:
151738
Hom.:
Cov.:
31
AF XY:
AC XY:
23463
AN XY:
74098
Gnomad4 AFR
AF:
AC:
0.133211
AN:
0.133211
Gnomad4 AMR
AF:
AC:
0.298937
AN:
0.298937
Gnomad4 ASJ
AF:
AC:
0.350634
AN:
0.350634
Gnomad4 EAS
AF:
AC:
0.370097
AN:
0.370097
Gnomad4 SAS
AF:
AC:
0.354799
AN:
0.354799
Gnomad4 FIN
AF:
AC:
0.373425
AN:
0.373425
Gnomad4 NFE
AF:
AC:
0.421996
AN:
0.421996
Gnomad4 OTH
AF:
AC:
0.34188
AN:
0.34188
Heterozygous variant carriers
0
1552
3104
4656
6208
7760
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
494
988
1482
1976
2470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1149
AN:
3474
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at